Cite

MLA Citation

    E. Brennan et al.. “What proportion of patients with stage I NSCLC seen in the oncology clinic are treated with SABR?.” Lung cancer, vol. 139, n.d., pp. S32–. http://access.bl.uk/ark:/81055/vdc_100099354328.0x000043
  
Back to record